Literature DB >> 7637022

Nucleotide sequence variation of the envelope protein gene identifies two distinct genotypes of yellow fever virus.

G J Chang1, B C Cropp, R M Kinney, D W Trent, D J Gubler.   

Abstract

The evolution of yellow fever virus over 67 years was investigated by comparing the nucleotide sequences of the envelope (E) protein genes of 20 viruses isolated in Africa, the Caribbean, and South America. Uniformly weighted parsimony algorithm analysis defined two major evolutionary yellow fever virus lineages designated E genotypes I and II. E genotype I contained viruses isolated from East and Central Africa. E genotype II viruses were divided into two sublineages: IIA viruses from West Africa and IIB viruses from America, except for a 1979 virus isolated from Trinidad (TRINID79A). Unique signature patterns were identified at 111 nucleotide and 12 amino acid positions within the yellow fever virus E gene by signature pattern analysis. Yellow fever viruses from East and Central Africa contained unique signatures at 60 nucleotide and five amino acid positions, those from West Africa contained unique signatures at 25 nucleotide and two amino acid positions, and viruses from America contained such signatures at 30 nucleotide and five amino acid positions in the E gene. The dissemination of yellow fever viruses from Africa to the Americas is supported by the close genetic relatedness of genotype IIA and IIB viruses and genetic evidence of a possible second introduction of yellow fever virus from West Africa, as illustrated by the TRINID79A virus isolate. The E protein genes of American IIB yellow fever viruses had higher frequencies of amino acid substitutions than did genes of yellow fever viruses of genotypes I and IIA on the basis of comparisons with a consensus amino acid sequence for the yellow fever E gene. The great variation in the E proteins of American yellow fever virus probably results from positive selection imposed by virus interaction with different species of mosquitoes or nonhuman primates in the Americas.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7637022      PMCID: PMC189439     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Comparative immunochemical and biological analysis of African and South American yellow fever viruses.

Authors:  V Deubel; J J Schlesinger; J P Digoutte; M Girard
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

2.  Partial nucleotide sequence of St. Louis encephalitis virus RNA: structural proteins, NS1, ns2a, and ns2b.

Authors:  D W Trent; R M Kinney; B J Johnson; A V Vorndam; J A Grant; V Deubel; C M Rice; C Hahn
Journal:  Virology       Date:  1987-02       Impact factor: 3.616

3.  Cloning full-length dengue type 4 viral DNA sequences: analysis of genes coding for structural proteins.

Authors:  B Zhao; E Mackow; A Buckler-White; L Markoff; R M Chanock; C J Lai; Y Makino
Journal:  Virology       Date:  1986-11       Impact factor: 3.616

4.  Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it.

Authors:  C S Hahn; J M Dalrymple; J H Strauss; C M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

5.  Sequence of the dengue-1 virus genome in the region encoding the three structural proteins and the major nonstructural protein NS1.

Authors:  P W Mason; P C McAda; T L Mason; M J Fournier
Journal:  Virology       Date:  1987-11       Impact factor: 3.616

6.  Genetic heterogeneity of yellow fever virus strains from Africa and the Americas.

Authors:  V Deubel; J P Digoutte; T P Monath; M Girard
Journal:  J Gen Virol       Date:  1986-01       Impact factor: 3.891

7.  Complete nucleotide sequence of the Japanese encephalitis virus genome RNA.

Authors:  H Sumiyoshi; C Mori; I Fuke; K Morita; S Kuhara; J Kondou; Y Kikuchi; H Nagamatu; A Igarashi
Journal:  Virology       Date:  1987-12       Impact factor: 3.616

8.  The in vivo differentiation of strains of yellow fever virus in mice.

Authors:  R Fitzgeorge; C J Bradish
Journal:  J Gen Virol       Date:  1980-01       Impact factor: 3.891

9.  Comparison of neurovirulence of different strains of yellow fever virus in mice.

Authors:  A D Barrett; E A Gould
Journal:  J Gen Virol       Date:  1986-04       Impact factor: 3.891

10.  Antigenic analysis of certain group B arthropodborne viruses by antibody absorption.

Authors:  D H CLARKE
Journal:  J Exp Med       Date:  1960-01-01       Impact factor: 14.307

View more
  16 in total

1.  Phylogenetic and evolutionary relationships among yellow fever virus isolates in Africa.

Authors:  J P Mutebi; H Wang; L Li; J E Bryant; A D Barrett
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Homogeneity of yellow fever virus strains isolated during an epidemic and a post-epidemic period in West Africa.

Authors:  M R Pisano; J Nicoli; H Tolou
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

3.  Genomic and phylogenetic characterization of Brazilian yellow fever virus strains.

Authors:  Marcio R T Nunes; Gustavo Palacios; Jedson F Cardoso; Livia C Martins; Edivaldo C Sousa; Clayton P S de Lima; Daniele B A Medeiros; Nazir Savji; Aaloki Desai; Sueli G Rodrigues; Valeria L Carvalho; W Ian Lipkin; Pedro F C Vasconcelos
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

4.  Adaptive Diversification Between Yellow Fever Virus West African and South American Lineages: A Genome-Wide Study.

Authors:  Yan Li; Zexiao Yang
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

5.  Interaction of yellow fever virus French neurotropic vaccine strain with monkey brain: characterization of monkey brain membrane receptor escape variants.

Authors:  H Ni; K D Ryman; H Wang; M F Saeed; R Hull; D Wood; P D Minor; S J Watowich; A D Barrett
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

6.  Yellow Fever Virus Reemergence and Spread in Southeast Brazil, 2016-2019.

Authors:  Marta Giovanetti; Marcos Cesar Lima de Mendonça; Vagner Fonseca; Maria Angélica Mares-Guia; Allison Fabri; Joilson Xavier; Jaqueline Goes de Jesus; Tiago Gräf; Cintia Damasceno Dos Santos Rodrigues; Carolina Cardoso Dos Santos; Simone Alves Sampaio; Flavia Lowen Levy Chalhoub; Fernanda de Bruycker Nogueira; Julien Theze; Alessandro Pecego Martins Romano; Daniel Garkauskas Ramos; Andre Luiz de Abreu; Wanderson Kleber Oliveira; Rodrigo Fabiano do Carmo Said; Carlos F Campelo de Alburque; Tulio de Oliveira; Carlos Augusto Fernandes; Shirlei Ferreira Aguiar; Alexandre Chieppe; Patrícia Carvalho Sequeira; Nuno Rodrigues Faria; Rivaldo Venâncio Cunha; Luiz Carlos Junior Alcantara; Ana Maria Bispo de Filippis
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

7.  Yellow fever virus maintenance in Trinidad and its dispersal throughout the Americas.

Authors:  Albert J Auguste; Philippe Lemey; Oliver G Pybus; Marc A Suchard; Rosa Alba Salas; Abiodun A Adesiyun; Alan D Barrett; Robert B Tesh; Scott C Weaver; Christine V F Carrington
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

8.  Yellow fever virus exhibits slower evolutionary dynamics than dengue virus.

Authors:  Amadou A Sall; Ousmane Faye; Mawlouth Diallo; Cadhla Firth; Andrew Kitchen; Edward C Holmes
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

9.  Biological and phylogenetic characteristics of yellow fever virus lineages from West Africa.

Authors:  Nina K Stock; Hewád Laraway; Ousmane Faye; Mawlouth Diallo; Matthias Niedrig; Amadou A Sall
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

10.  Current Assessment of Yellow Fever and Yellow Fever Vaccine.

Authors:  Anabelle Lefeuvre; Philippe Marianneau; Vincent Deubel
Journal:  Curr Infect Dis Rep       Date:  2004-04       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.